We are live on
!
Find out more
AAF
Andra AP-fonden Portfolio holdings
AUM
$8.39B
1-Year Est. Return
21.19%
This Fund
S&P 500
This Quarter
Est. Return
-0.07%
1 Year Est. Return
+21.19%
3 Year Est. Return
+70.53%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.86B
AUM Growth
-$38.5M
(-0.79%)
Cap. Flow
+$72.4M
Cap. Flow
% of AUM
1.49%
Top 10 Holdings %
Top 10 Hldgs %
4.3%
Holding
618
New
24
Increased
289
Reduced
263
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$19.3M |
| 2 |
Bath & Body Works
BBWI
|
+$11.5M |
| 3 |
Chubb
CB
|
+$10.8M |
| 4 |
Upstart Holdings
UPST
|
+$10.5M |
| 5 |
AbbVie
ABBV
|
+$9.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$22M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$13.1M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$7.48M |
| 4 |
Reinsurance Group of America
RGA
|
+$7.02M |
| 5 |
XPO
XPO
|
+$6.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.83% |
| 2 | Healthcare | 16.68% |
| 3 | Financials | 13.87% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Industrials | 11.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTLT
501
DELISTED
CATALENT, INC.
CTLT
| $3.41M | 0.07% |
+25,600
| New | +$3.2M |
|
|
OSH
502
DELISTED
Oak Street Health, Inc.
OSH
| $3.41M | 0.07% |
80,100
+300
| +0.4% | +$16.1K |
|
503
Wabtec
WAB
$49.3B
| $3.32M | 0.07% |
38,500
-8,200
| -18% | -$706K |
|
504
Broadcom
AVGO
$2.04T
| $3.3M | 0.07% |
68,000
| – | – |
|
|
JOYY
505
JOYY Inc
JOYY
$3.75B
| $3.29M | 0.07% |
60,000
-6,200
| -9% | -$347K |
|
506
Markel Group
MKL
$23.2B
| $3.29M | 0.07% |
2,750
-1,040
| -27% | -$1.28M |
|
507
Cable One
CABO
$212M
| $3.26M | 0.07% |
1,800
+100
| +6% | +$196K |
|
508
KE Holdings
BEKE
$18.8B
| $3.23M | 0.07% |
176,800
+30,000
| +20% | +$731K |
|
509
Twilio
TWLO
$36.6B
| $3.22M | 0.07% |
10,100
-1,500
| -13% | -$546K |
|
510
Qfin Holdings
QFIN
$1.61B
| $3.22M | 0.07% |
158,500
+49,600
| +46% | +$1.17M |
|
511
Restaurant Brands International
QSR
$25.8B
| $3.16M | 0.07% |
40,700
-500
| -1% | -$32K |
|
|
NBP
512
NovaBridge Biosciences American Depositary Shares
NBP
$202M
| $3.15M | 0.06% |
43,500
+8,200
| +23% | +$593K |
|
|
BZUN
513
Baozun
BZUN
$172M
| $3.15M | 0.06% |
179,700
+31,900
| +22% | +$785K |
|
514
Edison International
EIX
$26.4B
| $3.11M | 0.06% |
56,000
-20,800
| -27% | -$1.19M |
|
515
Credicorp
BAP
$30.7B
| $3.07M | 0.06% |
27,700
| – | – |
|
516
FedEx
FDX
$75.4B
| $3.05M | 0.06% |
13,900
+2,700
| +24% | +$733K |
|
|
SJR
517
DELISTED
Shaw Communications Inc.
SJR
| $3.04M | 0.06% |
82,500
-26,300
| -24% | -$762K |
|
518
Sea Limited
SE
$69.5B
| $3.03M | 0.06% |
+9,500
| New | +$2.92M |
|
519
AGNC Investment
AGNC
$12.9B
| $3M | 0.06% |
190,100
-127,600
| -40% | -$2.07M |
|
520
Steris
STE
$23.1B
| $2.98M | 0.06% |
14,600
-5,500
| -27% | -$1.18M |
|
|
MASI
521
DELISTED
Masimo
MASI
| $2.95M | 0.06% |
10,900
-300
| -3% | -$81.3K |
|
522
Roper Technologies
ROP
$39.8B
| $2.94M | 0.06% |
6,600
+4,100
| +164% | +$1.96M |
|
|
MOMO
523
Hello Group
MOMO
$866M
| $2.92M | 0.06% |
+275,500
| New | +$3.45M |
|
524
Celanese
CE
$4.82B
| $2.91M | 0.06% |
19,300
-2,100
| -10% | -$323K |
|
525
Charles River Laboratories
CRL
$12.8B
| $2.89M | 0.06% |
7,000
+1,400
| +25% | +$581K |
|
Similar funds
NW
GGHC
FT
DM
GRQ
PCM
IC
NB
Andra AP-fonden's Q3 2021 Portfolio in Review
As of Q3 2021, Andra AP-fonden held 618 positions worth $4.86B, down 0.79% from $4.9B the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.
Andra AP-fonden's Q3 2021 filing shows 24 new, 289 increased, 263 reduced and 21 closed positions. Its largest new stake was Analog Devices: 115,031 shares worth $19.3M. The largest sale was Alexion Pharmaceuticals, an estimated $22M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Andra AP-fonden's largest Q3 2021 buy was Analog Devices: 115,031 shares worth $19.3M.
- Andra AP-fonden added most to Otis Worldwide in Q3 2021, an estimated $4.8M increase.
- Andra AP-fonden's biggest Q3 2021 reduction was Jazz Pharmaceuticals, cutting an estimated $5.36M.
- Andra AP-fonden fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $22M.
- Andra AP-fonden's ten largest holdings make up 4.3% of its $4.86B portfolio in Q3 2021.
- Andra AP-fonden opened 24 new positions and closed 21 in Q3 2021.
- Andra AP-fonden's portfolio value fell 0.79% quarter-over-quarter to $4.86B.
Based on Andra AP-fonden's 13F filing for Q3 2021, filed 12 Nov 2021.